Beta-adrenergic blockade reversal of catabolism after severe burn
A technique for epinephrine and severe burns, applied in the field of beta-adrenergic antagonists, treating individuals with severe burns, and can solve the problem that there is no effective method for reducing the catabolism of muscle protein in burn patients.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] subjects
[0026] The study was approved by The University of Texas Medical Branch Institutional Review Board, and written informed consent was obtained from each patient's guardian. Inclusion criteria were: children under 18 years of age with burns greater than 40% total surface area (TBSA) and transferred to hospital within one week of injury. Patients with a known history of asthma were excluded.
[0027] Within 48 hours of admission, each patient's burnt portion was excised and autograft and allograft skin were transplanted. The patient is returned to the operating room after the autograft donor site has healed (6-10 days). The grafting procedure then continues in stages until the wound is closed.
[0028] Individual patients received nutrition containing Vivonex TEN (Sandoz Nutritionals, Minneapolis, MN) via a naso-duodenal tube. Deliver the daily calorie intake at a calculated rate of 1500 kcal per square meter of total surface area burned + 1500 kcal per sq...
Embodiment 2
[0030] Research design
[0031] From January 1999 to December 1999, 25 subjects underwent a forward randomized trial. Thirteen of them received propranolol and the other 12 served as untreated controls. Group with random number table.
[0032]After the first surgery, metabolic tests were performed on all subjects on day 5 after surgery. Resting energy expenditure (REE) and net protein balance of legs were measured as primary output variables. In addition, baseline total body potassium scans were performed on all subjects to determine fat-free body mass. After the second surgery, propranolol subjects started oral propranolol at a dose of 0.33 mg / kg every 4 hours (1.98 mg / kg / day). This dose was adjusted to reduce the subject's heart rate by 25% compared to the patient's 24-hour average heart rate before drug treatment. Heart rate and blood pressure were monitored continuously during the study. Maintain and / or reduce propranolol dose when blood pressure is below the mean ...
Embodiment 3
[0035] vital signs
[0036] Temperature, heart rate, systolic and diastolic blood pressure were measured hourly by standard continuous bladder temperature monitor, ECG monitor, and arterial catheter. The mean values for each 24-hour period were determined for each patient. Heart rates were compared between groups during the study. Additional analyzes were performed between groups on the day of the stable isotope study or varied by treatment.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 